| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.10B | 19.65B | 17.03B | 15.35B | 16.07B | 12.74B |
| Gross Profit | 5.30B | 4.65B | 6.29B | 5.70B | 5.45B | 4.07B |
| EBITDA | 2.66B | 2.58B | 1.66B | 1.45B | 1.17B | 881.00M |
| Net Income | 1.37B | 1.27B | 729.00M | 529.00M | 504.00M | 308.00M |
Balance Sheet | ||||||
| Total Assets | 21.23B | 20.19B | 18.20B | 13.32B | 12.76B | 12.02B |
| Cash, Cash Equivalents and Short-Term Investments | 1.55B | 2.08B | 1.08B | 1.85B | 1.57B | 1.96B |
| Total Debt | 5.41B | 5.21B | 5.38B | 3.10B | 3.07B | 3.73B |
| Total Liabilities | 14.12B | 13.51B | 12.90B | 9.35B | 8.98B | 8.93B |
| Stockholders Equity | 6.91B | 6.47B | 5.09B | 3.78B | 3.58B | 2.92B |
Cash Flow | ||||||
| Free Cash Flow | 1.20B | 1.18B | 1.14B | 792.00M | 584.00M | 494.00M |
| Operating Cash Flow | 1.94B | 1.93B | 1.93B | 1.42B | 1.04B | 777.00M |
| Investing Cash Flow | -1.19B | -1.06B | -4.85B | -491.00M | -498.00M | -582.00M |
| Financing Cash Flow | 193.00M | 173.00M | 2.20B | -424.00M | -961.00M | 335.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €1.46B | 19.92 | 21.53% | 2.75% | 9.32% | 8.88% | |
72 Outperform | €42.82B | 30.87 | 22.15% | 0.93% | 10.97% | 94.23% | |
66 Neutral | €8.53B | ― | 13.05% | 6.99% | 6.52% | 1.86% | |
58 Neutral | €120.65M | 20.24 | 4.08% | ― | 8.52% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | €2.43B | 6.39 | 15.02% | 2.32% | 14.59% | 23.80% |